| Rosa Jung Hensley, LCSW | |
|
4141 B St Ste 305, Anchorage, AK 99503-5941 | |
| (907) 921-1331 | |
| (907) 802-6630 |
| Full Name | Rosa Jung Hensley |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4141 B St Ste 305, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578846101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 144329 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosa Jung Hensley, LCSW 4141 B St Ste 305, Anchorage, AK 99503-5941 Ph: (907) 921-1331 | Rosa Jung Hensley, LCSW 4141 B St Ste 305, Anchorage, AK 99503-5941 Ph: (907) 921-1331 |
News Archive
Biotie announced today that it has reached a milestone in its collaboration with Wyeth for the development of PDE10 (phosphodiesterase 10) inhibitors for schizophrenia, triggering a USD 1.0 million milestone payment to Biotie.
Bruker today announced the successful installation of an Ascend™ Aeon 900 magnet, the world's first compact, single-story NMR magnet with active refrigeration at the University of California, San Diego (UCSD) in La Jolla, CA.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center (YCC). The data was published today in the journal The Lancet.
› Verified 3 days ago
Mrs. April Shinora Mclamb, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 600 W 41st Ave Ste 203b, Anchorage, AK 99503 Phone: 907-412-3487 | |
Shelley Lenee Reppel, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3820 Lake Otis Pkwy, Suite 100, Anchorage, AK 99508 Phone: 907-569-6906 Fax: 907-569-6908 | |
Ms. Constance Matthews Greco, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10250 Jamestown Dr Apt 15, Anchorage, AK 99507 Phone: 907-522-8170 | |
Anna M. Stafford, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4130 San Ernesto Ave, Anchorage, AK 99508 Phone: 907-729-5070 | |
Joshua Aaron Goldstein, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3000 C St Ste 202, Anchorage, AK 99503 Phone: 907-729-8558 | |
Megan Hultquist, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3300 Providence Dr, Suite B314, Anchorage, AK 99508 Phone: 907-212-3420 Fax: 907-212-3429 | |
Ulani Vinesa Luafulu, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2910 W 32nd Ave Apt 3, Anchorage, AK 99517 Phone: 907-726-3585 |